** Aveanna Healthcare Holdings' AVAH.O shares rise 17.1% to $4.38 during pre-market trading
** Atlanta-based company expects FY25 rev to be between $2.10 - $2.12 billion, mid-point of which is in line with analysts' estimates of $2.11 billion - LSEG
** Co posts Q4 revenue of $519.9 million, beating analyst estimates of $499.6 million
** "We expect continued organic volume growth, improved clinical outcomes, and enhanced profitability into 2025" - CFO Matt Buckhalter
** Including session's gain, co's shares down about 18% YTD
(Reporting by Bageshri Banerjee)
((bageshri.banerjee@thomsonreuters.com; Ph: 7003700554))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。